Quick Answer
Phio Pharmaceuticals Corp. reported Long Term Debt of $0.00 for the year ending 2021.
- Phio Pharmaceuticals Corp. showed a decrease of -100.0% in Long Term Debt from 2020 to 2021.
- This data is from Phio Pharmaceuticals Corp.'s annual report (Form 10-K), filed with the SEC on March 22, 2022.
- XBRL data for this metric is available from 2019 to 2021 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $231.0 thousand | Q3 2020: $231.0 thousand | Q1 2021: $0.00 | Q2 2021: $0.00 | Q3 2021: $0.00.
- Historical annual values: Fiscal year 2021: $0.00 | Fiscal year 2020: $231.0 thousand | Fiscal year 2019: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: